| Gilead Initiates Phase III Clinical Program Evaluating Single-Tablet, Once ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Renal impairment, including cases of acute renal failure and Fanconi syndrome (renal tubular injury with severe hypophosphatemia), has been reported in ... read more |